Celltrion Healthcare Co Ltd
KOSDAQ:091990
Balance Sheet
Balance Sheet Decomposition
Celltrion Healthcare Co Ltd
Current Assets | 4.5T |
Cash & Short-Term Investments | 433.4B |
Receivables | 1.3T |
Other Current Assets | 2.7T |
Non-Current Assets | 182.2B |
Long-Term Investments | 2.8B |
PP&E | 10.3B |
Intangibles | 12.3B |
Other Non-Current Assets | 156.8B |
Current Liabilities | 2.5T |
Accounts Payable | 1.7T |
Accrued Liabilities | 87.5B |
Short-Term Debt | 292.5B |
Other Current Liabilities | 447.2B |
Non-Current Liabilities | 135.8B |
Long-Term Debt | 4.6B |
Other Non-Current Liabilities | 131.3B |
Balance Sheet
Celltrion Healthcare Co Ltd
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash & Cash Equivalents |
4 426
|
36 861
|
95 867
|
251 366
|
240 369
|
296 966
|
231 494
|
254 941
|
458 004
|
|
Cash |
11
|
5
|
14
|
15
|
14
|
3
|
0
|
0
|
0
|
|
Cash Equivalents |
4 415
|
36 856
|
95 853
|
251 351
|
240 355
|
296 963
|
231 494
|
254 941
|
458 004
|
|
Short-Term Investments |
0
|
0
|
0
|
520 000
|
330 708
|
160 621
|
295 695
|
267 130
|
71 088
|
|
Total Receivables |
40 852
|
62 152
|
364 283
|
420 530
|
448 218
|
549 230
|
847 621
|
977 397
|
1 220 821
|
|
Accounts Receivables |
40 781
|
62 089
|
364 147
|
418 753
|
446 614
|
518 438
|
750 503
|
925 259
|
1 016 672
|
|
Other Receivables |
71
|
63
|
136
|
1 777
|
1 604
|
30 792
|
97 118
|
52 138
|
204 150
|
|
Inventory |
1 186 797
|
1 399 285
|
1 472 120
|
1 574 799
|
1 696 910
|
1 623 600
|
2 034 551
|
2 065 737
|
2 352 890
|
|
Other Current Assets |
9 731
|
14 164
|
16 883
|
33 526
|
77 172
|
35 854
|
89 501
|
137 536
|
172 864
|
|
Total Current Assets |
1 241 806
|
1 512 462
|
1 949 153
|
2 800 221
|
2 793 377
|
2 666 271
|
3 498 862
|
3 702 742
|
4 275 666
|
|
PP&E Net |
345
|
193
|
112
|
315
|
362
|
2 394
|
6 211
|
7 116
|
9 416
|
|
PP&E Gross |
345
|
193
|
112
|
315
|
362
|
2 394
|
6 211
|
7 116
|
9 416
|
|
Accumulated Depreciation |
547
|
705
|
842
|
917
|
1 002
|
2 447
|
3 678
|
5 584
|
8 041
|
|
Intangible Assets |
119
|
221
|
282
|
1 338
|
2 152
|
1 906
|
3 820
|
3 829
|
6 392
|
|
Goodwill |
734
|
734
|
734
|
734
|
734
|
734
|
734
|
734
|
6 200
|
|
Note Receivable |
34 137
|
30 740
|
2 142
|
3 973
|
4 152
|
0
|
0
|
6
|
192
|
|
Long-Term Investments |
0
|
18 882
|
23 100
|
50 285
|
32 658
|
27 072
|
3 983
|
4 384
|
2 256
|
|
Other Long-Term Assets |
106 558
|
12 293
|
11 918
|
18 079
|
115 135
|
150 529
|
226 088
|
195 883
|
154 476
|
|
Other Assets |
734
|
734
|
734
|
734
|
734
|
734
|
734
|
734
|
6 200
|
|
Total Assets |
1 383 699
N/A
|
1 575 526
+14%
|
1 987 441
+26%
|
2 874 946
+45%
|
2 948 569
+3%
|
2 848 905
-3%
|
3 739 698
+31%
|
3 914 694
+5%
|
4 454 599
+14%
|
|
Liabilities | ||||||||||
Accounts Payable |
326 027
|
580 201
|
641 305
|
659 243
|
646 329
|
570 678
|
955 355
|
736 087
|
1 441 494
|
|
Accrued Liabilities |
18 296
|
11 033
|
5 032
|
7 468
|
1 795
|
22 297
|
95 634
|
24 893
|
148 633
|
|
Short-Term Debt |
10 993
|
9 360
|
22 666
|
11 269
|
16 824
|
114 429
|
197 634
|
398 927
|
358 658
|
|
Current Portion of Long-Term Debt |
165 922
|
5 789
|
166 109
|
0
|
0
|
1 147
|
2 232
|
2 417
|
3 681
|
|
Other Current Liabilities |
531 780
|
93 892
|
308 260
|
315 364
|
614 187
|
362 522
|
406 919
|
481 889
|
292 436
|
|
Total Current Liabilities |
1 053 018
|
700 275
|
1 143 372
|
993 344
|
1 279 135
|
1 071 072
|
1 657 774
|
1 644 213
|
2 244 902
|
|
Long-Term Debt |
144 604
|
154 563
|
0
|
0
|
0
|
788
|
3 053
|
3 535
|
4 309
|
|
Deferred Income Tax |
0
|
0
|
0
|
161
|
232
|
4
|
41 492
|
61 431
|
61 442
|
|
Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
870 748
|
221 010
|
195 416
|
173 967
|
33 723
|
111 147
|
104 449
|
99 748
|
82 154
|
|
Total Liabilities |
2 068 370
N/A
|
1 075 847
-48%
|
1 338 788
+24%
|
1 167 472
-13%
|
1 313 091
+12%
|
1 183 011
-10%
|
1 806 769
+53%
|
1 808 927
+0%
|
2 392 807
+32%
|
|
Equity | ||||||||||
Common Stock |
1 658
|
2 772
|
112 084
|
137 338
|
140 527
|
143 928
|
151 810
|
155 028
|
158 242
|
|
Retained Earnings |
797 244
|
776 660
|
205 603
|
264 698
|
267 463
|
329 641
|
562 932
|
712 496
|
816 753
|
|
Additional Paid In Capital |
144 211
|
1 323 556
|
380 642
|
1 365 601
|
1 377 026
|
1 390 657
|
1 408 552
|
1 412 551
|
1 417 272
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
7
|
167
|
11
|
89
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
96 165
|
114 060
|
116 968
|
128 592
|
219 641
|
|
Other Equity |
33 296
|
49 990
|
49 677
|
60 164
|
53 371
|
84 279
|
73 229
|
45 726
|
110 924
|
|
Total Equity |
684 671
N/A
|
499 679
N/A
|
648 653
+30%
|
1 707 473
+163%
|
1 635 478
-4%
|
1 665 894
+2%
|
1 932 930
+16%
|
2 105 768
+9%
|
2 061 791
-2%
|
|
Total Liabilities & Equity |
1 383 699
N/A
|
1 575 526
+14%
|
1 987 441
+26%
|
2 874 946
+45%
|
2 948 569
+3%
|
2 848 905
-3%
|
3 739 698
+31%
|
3 914 694
+5%
|
4 454 599
+14%
|
|
Shares Outstanding | ||||||||||
Common Shares Outstanding |
74
|
124
|
125
|
153
|
152
|
152
|
153
|
159
|
161
|